Search
for
Sort by
Research 661–690 of 1000+
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- 222 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- PD20-08 INVESTIGATION OF SEXUAL DYSFUNCTION LINKED TO FINASTERIDE USE: A PHARMACOVIGILANCE ANALYSIS
- Faculty Opinions recommendation of Post-finasteride syndrome: a surmountable challenge for clinicians.
- Dutasteride/finasteride
- Post-finasteride syndrome: our current knowledge
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- Safety and Efficacy of the Coadministration of Sildenafil and Finasteride
- Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP
- Finasteride drug safety alert
- Risk of muscular adverse effects with finasteride
- MP13-07 FINASTERIDE MONOTHERAPY BEFORE TURP: SIGNIFICANT IMPROVEMENT IN EARLY POSTOPERATIVE QUALITY OF LIFE
- No increased risk of CV events with dutasteride vs finasteride
- Dutasteride, finasteride: no increased risk of ED
- 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy
- No clear link between finasteride and suicidality
- Faculty Opinions recommendation of Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Finasteride
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- Luncheon Symposium (LS) : Update on the efficacy and safety of dutasteride in the management of androgenetic alopecia
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- Urinary symptoms in patients with androgenetic alopecia
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Dutasteride for Androgenetic Alopecia—Words of Caution
- Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
- Editorial Comment
- 5 Alpha-reductase inhibitors: whatʼs new?
- How do we investigate haematuria and what role has finasteride?